糖尿病预防计划参与者纵向代谢轨迹揭示不同微血管和大血管并发症风险亚组
研究分析1732名糖尿病预防计划/结局研究参与者19年随访数据,用张量分解和高斯混合模型识别出四种纵向代谢轨迹集群。两个集群(占73%)代谢稳定且并发症低,一个集群胰岛素抵抗和高血糖快速进展伴视网膜病变和神经病变风险升高,另一个集群以基线微量白蛋白尿和肾功能下降为特征且心血管事件风险加倍。
要点
- 约73%的糖尿病前期个体代谢轨迹稳定,微血管和大血管事件累积率低。
- 胰岛素抵抗和高血糖快速进展亚组视网膜病变OR 8.8、神经病变OR 3.4。
- 基线微量白蛋白尿亚组心血管事件风险比2.0,可发生在糖尿病发病前。
核心结论
- 约三分之二的糖尿病前期个体遵循代谢稳定轨迹,而不同的胰岛素抵抗或肾功能障碍轨迹分别先于微血管或大血管并发症出现。
- 糖尿病前期微量白蛋白尿个体的大血管并发症预防最佳窗口可能早于进展为2型糖尿病。
研究设计与样本
- 分析1732名糖尿病预防计划/结局研究参与者的临床数据,随访19年,涵盖12种表型。
- 采用张量分解捕捉纵向模式,高斯混合模型定义纵向集群,用Cox和逻辑回归量化集群特异性并发症。
主要发现
- 共出现四个集群;集群1和2(占73%)保持血糖、血压和血脂稳定,分别有49%和71%进展为2型糖尿病,但累积微血管和大血管事件仍低。
- 集群3(12%)胰岛素抵抗和高血糖上升最陡,92%进展为2型糖尿病,视网膜病变OR 8.8(95%CI 3.9-20.1),神经病变OR 3.4(95%CI 2.1-5.5)。
- 集群4(15%)基线微量白蛋白尿常在2型糖尿病发生前(73%),以估算肾小球滤过率进行性下降为特征,心血管事件风险比2.0(95%CI 1.4-3.0),尽管血脂与其他组相当。
临床怎么用
- 对糖尿病前期个体应识别代谢轨迹亚型,胰岛素抵抗快速进展者重点筛查视网膜和神经病变。
- 基线微量白蛋白尿者即使血脂正常也应加强心血管风险评估,干预窗口可能早于糖尿病发病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Type 2 diabetes (T2D) and its associated complications develop heterogeneously over decades, but few studies span the progression from prediabetes to clinical events. We investigated whether long-term metabolic trajectories beginning in prediabetes delineate subgroups with differential complication risk. RESEARCH DESIGN AND METHODS: Clinical data from 1,732 Diabetes Prevention Program/Outcomes Study participants (follow-up 19 years) were analyzed across 12 phenotypes. Tensor decomposition was used to capture longitudinal patterns, and Gaussian mixture modeling was used to define longitudinal clusters. Cluster-specific complications were quantified with Cox and logistic regression. RESULTS: Four clusters emerged. Clusters 1 and 2 (73% of participants) maintained stable glycemia, blood pressure, and lipids. Although 49% and 71%, respectively, developed T2D, cumulative micro- and macrovascular events remained low. Cluster 3 (12%) showed the steepest rise in insulin resistance and hyperglycemia, with 92% of the subgroup progressing to T2D and a markedly higher rate of retinopathy (odds ratio [OR] 8.8, 95% CI 3.9-20.1) and neuropathy (OR 3.4, 95% CI 2.1-5.5). Cluster 4 (15%) presented with baseline microalbuminuria often prior to the development of T2D (73%). It was distinguished by progressive estimated glomerular filtration rate decline and a doubling of cardiovascular events (hazard ratio 2.0, 95% CI 1.4-3.0), despite serum lipids comparable with other groups. CONCLUSIONS: Two-thirds of individuals with prediabetes follow metabolically resilient trajectories, whereas distinct insulin-resistant or renal-dysfunction trajectories precede micro- or macrovascular complications, respectively. The optimal window for macrovascular complication prevention in individuals with prediabetes microalbuminuria may precede progression to T2D.
引用
- Kobayashi E, Linden-Santangeli NJ, Chan N, et al. Longitudinal Metabolic Trajectories in Diabetes Prevention Program Participants Reveal Subgroups With Varying Micro- and Macrovascular Complication Risks. Diabetes Care. 2025. PMID: 40857122. doi:10.2337/dc25-0866
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。